Philips Says Comparable Sales Growth Flat

Phillips reports flat comparable sales growth for the third quarter, with earnings slightly below analyst expectations. The company is focusing on health and technology sectors, aiming to integrate healthcare and technology. Plans are underway to separate the lighting division, marking a significant shift. Phillips is also dealing with a €365 million charge from a patent case loss against Massimo in the U.S., which they are appealing.

What are analysts expecting in terms of earnings, and how does it compare to the actual earnings mentioned?

What was the amount involved in the patent case against Massimo core?